Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CVRx Inc.
CVRX | US
8.37
USD-0.12
-1.41%
CVRX | US
About CVRx Inc.
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
05/03/2026
Close
8.37
Open
8.34
High
8.49
Low
8.05
CVRx Inc. a commercial-stage medical device company focuses on developing manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force as well as sales agents and independent distributors in the United States Germany and internationally. CVRx Inc. was incorporated in 2000 and is headquartered in Minneapolis Minnesota.
View LessCVRX | US
Risk
103.6
Sharpe
-0.36
Luna's Score
48/100
Recommendation
Hold
Luna says (CVRX | US)
What's Working
Positive Momentum
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
83.3%1 month
103.6%3 months
91.3%6 months
76.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.19
Debt to equity
0.55
Debt to assets
0.32
Ent. to EBITDA
-1.31
Ent. to rev.
3.08
PEG
-
Other Fundamentals
EBITDA
-54.86M
MarketCap
155.64M
MarketCap(USD)
155.64M
Div. yield
-
Op. margin
-118.35
Erngs. growth
-
Rev. growth
24.30
Ret. on equity
-74.91
Short ratio
9.37
Short perc.
14.90
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
3.87
Range1M
4.32
Range3M
5.26
Volumes: Market Activity
Rel. volume
0.44
Price X volume
1.62M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.31 | - | Cheaper |
| Ent. to Revenue | 3.08 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 3.19 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 91.26 | - | Riskier |
| Debt to Equity | 0.55 | -145.53 | Expensive |
| Debt to Assets | 0.32 | 0.35 | Par |
| Market Cap | 155.64M | - | Emerging |
